Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 15 | DeSimone JillDirector | Open-market sale · 10b5-1 plan | SELL | $382K 1,240 sh | Jun 26, 2026 |
| 14 | Venker EricPresident & Immunovant CEO | Open-market sale · 10b5-1 plan | SELL | $5.08M 153.8K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 14 | Chandhok NikhilChief Product & Tech. Officer | Open-market sale · 10b5-1 plan | SELL | $5.80M 78.9K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 14 | Seymour DavidEVP Chief Operating Officer | Open-market sale · 10b5-1 plan | SELL | $1.18M 69.3K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 14 | Chandhok NikhilChief Product & Tech. Officer | Open-market sale · 10b5-1 plan | SELL | $5.27M 73.7K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 14 | Chandhok NikhilChief Product & Tech. Officer | Open-market sale · 10b5-1 plan | SELL | $2.63M 35.2K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 14 | Seymour DavidEVP Chief Operating Officer | Open-market sale · 10b5-1 plan | SELL | $1.02M 56.5K sh | Jun 26, 2026 traded Jun 25, 2026 |
| 14 | Chandhok NikhilChief Product & Tech. Officer | Open-market sale · 10b5-1 plan | SELL | $7.93M 112.0K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 13 | Menu PhilippeChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $28K 5,000 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 13 | Rubin KevinChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $210K 1,696 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 13 | Rubin KevinChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $62K 504 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 13 | Rubin KevinChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $70K 560 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 12 | DeSimone JillDirector | Open-market sale · 10b5-1 plan | SELL | $158K 504 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 12 | DeSimone JillDirector | Open-market sale · 10b5-1 plan | SELL | $210K 683 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 12 | Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $1.28M 5,066 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 12 | Hancock MarkDirector, Co Fndr; Exec V Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $2.50M 61.7K sh | Jun 26, 2026 traded Jun 26, 2026 |
| 12 | Hancock MarkDirector, Co Fndr; Exec V Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $5.57M 138.1K sh | Jun 26, 2026 traded Jun 25, 2026 |
| 12 | Caldwell Jonathan L.Chief People Officer | Open-market sale · 10b5-1 plan | SELL | $114K 2,851 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 11 | Sakamoto Ryan T.EVP, Chief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $11K 2,978 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 11 | Islam NayaabSee Remarks | Open-market sale · 10b5-1 plan | SELL | $302K 25.1K sh | Jun 26, 2026 traded Jun 26, 2026 |
| 11 | Daunt JohnEVP, Chief Commercial Officer | Open-market sale · 10b5-1 plan | SELL | $296K 7,539 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 10 | Venker EricPresident & Immunovant CEO | Open-market sale · 10b5-1 plan | SELL | $1.55M 46.2K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 10 | Rubin KevinChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $29K 228 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 10 | Rubin KevinChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $1,521 12 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 9 | Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $302K 1,200 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 8 | Yeh Kuanling AmyChief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $33K 3,000 sh | Jun 26, 2026 traded Jun 26, 2026 |
| 8 | Simon Barry J.Director | Open-market sale · 10b5-1 plan | SELL | $197K 25.0K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 8 | DeSimone JillDirector | Open-market sale · 10b5-1 plan | SELL | $98K 320 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 8 | Daunt JohnEVP, Chief Commercial Officer | Open-market sale · 10b5-1 plan | SELL | $102K 2,600 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 5 | DeSimone JillDirector | Open-market sale · 10b5-1 plan | SELL | $36K 120 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 5 | Feld MichaelEVP, Chief Revenue Officer | Open-market sale · 10b5-1 plan | SELL | $11K 75 sh | Jun 26, 2026 traded Jun 26, 2026 |
| 5 | DeSimone JillDirector | Open-market sale · 10b5-1 plan | SELL | $3,014 10 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 4 | Chandhok NikhilChief Product & Tech. Officer | Open-market sale · 10b5-1 plan | SELL | $101K 1,334 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 3 | Hancock MarkDirector, Co Fndr; Exec V Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $8,202 200 sh | Jun 26, 2026 traded Jun 26, 2026 |
| 1 | Clark KyleDirector, SEE REMARKS | Open-market sale · 10b5-1 plan | SELL | $248K 15.0K sh | Jun 26, 2026 traded Jun 26, 2026 |
| 1 | Clark KyleDirector, SEE REMARKS | Open-market sale · 10b5-1 plan | SELL | $237K 15.0K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 1 | Clark KyleDirector, SEE REMARKS | Open-market sale · 10b5-1 plan | SELL | $237K 15.0K sh | Jun 26, 2026 traded Jun 25, 2026 |
| 50 | Wang LaiPresident, Global Head of R&D | Open-market sale | SELL | $296K 1,068 sh | Jun 25, 2026 traded Jun 23, 2026 |
| 47 | Wu XiaobinPresident and COO | Open-market sale | SELL | $357K 1,292 sh | Jun 25, 2026 traded Jun 23, 2026 |
| 42 | Leggett Michael AdamSr VP & Chief Supply Chain Off | Open-market sale | SELL | $375K 9,000 sh | Jun 25, 2026 traded Jun 24, 2026 |